top of page

The Future of Atrial Fibrillation Care Starts Here

Our device delivers precise, low-dose therapy and painless cardioversion to transform cardiac care.

heart.gif

We are a late-stage medical device company dedicated to improving patient quality of life through innovative, minimally invasive, and cost-efficient solutions that address unmet healthcare needs.

Postoperative atrial fibrillation (POAF) is a common complication after cardiac surgery, affecting up to 60% of patients, particularly in aging populations. POAF is a serious condition that must be treated to prevent severe outcomes like stroke, heart failure, and death.

What is AFIB?

​

The "Big Little Problem"

Healthcare Team Collaboration

Postoperative atrial fibrillation (POAF) is a major complication after cardiac surgery, causing longer hospital stays and increased patient costs. While treatments like IV antiarrhythmic drugs and external cardioversion restore normal heart rhythm, they come with serious side effects, including drug toxicity, burns, and pain.

Featured

bottom of page